Characteristics and risk factors of mortality in patients with systemic sclerosis-associated interstitial lung disease-Reference-Cited by-同舟云学术

Characteristics and risk factors of mortality in patients with systemic sclerosis-associated interstitial lung disease

Published:2023-02-22 Issue:1 Volume:55 Page:663-671
ISSN:0785-3890
Container-title:Annals of Medicine
language:en
Short-container-title:Annals of Medicine

Author:

Jang Hye Jin¹²,Woo Ala²,Kim Song Yee²,Yong Seung Hyun²,Park Youngmok²,Chung Kyungsoo²,Lee Su Hwan²,Leem Ah Young²,Lee Sang Hoon²,Kim Eun Young²,Jung Ji Ye²,Kang Young Ae²,Kim Young Sam²,Park Moo Suk²

Affiliation:

1. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Myongji Hospital, Hanyang Medical Center, Gyeonggi-do, Republic of Korea

2. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Republic of Korea

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/07853890.2023.2179659

Reference45 articles.

1. Scleroderma with Fibrosing Interstitial Lung Disease: Where Do We Stand?

2. Adult prevalence of systemic autoimmune rheumatic diseases (SARDs) in British Columbia, Canada;Sayre A;Arthritis Rheum,2011

3. Adigun R, Goyal A, Bansal P, et al. Systemic sclerosis. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2017.

4. Treatment of Systemic Sclerosis–related Interstitial Lung Disease: A Review of Existing and Emerging Therapies

5. Recent Advances in Understanding the Pathogenesis of Scleroderma-Interstitial Lung Disease

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the mechanism of luteolin improving immune and inflammatory responses in systemic sclerosis based on systems biology and cell experiments;International Immunopharmacology;2024-09

2. Development of a multivariable prediction model for progression of systemic sclerosis-associated interstitial lung disease;RMD Open;2024-09

3. Tuberculosis is the predominant infection in systemic sclerosis: thirty-year retrospective study of serious infections from a single centre;Rheumatology International;2024-08-24

4. Emergencies in inflammatory rheumatic diseases;Rheumatology International;2024-07-09

5. Prevalence of the limited vs. extensive scleroderma-related interstitial lung disease at the time of diagnosis of SSc-ILD based on Goh et al. criteria. Systematic review and meta-analysis;Revista Clínica Española (English Edition);2024-04